315 related articles for article (PubMed ID: 7473815)
21. Induction of apoptosis by a short-chain neuropeptide analog in small cell lung cancer.
Rosati R; Adil MR; Ali MA; Eliason J; Orosz A; Sebestyén F; Kalemkerian GP
Peptides; 1998; 19(9):1519-23. PubMed ID: 9864058
[TBL] [Abstract][Full Text] [Related]
22. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
23. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells.
Um SJ; Lee SY; Kim EJ; Han HS; Koh YM; Hong KJ; Sin HS; Park JS
Cancer Lett; 2001 Dec; 174(2):127-34. PubMed ID: 11689287
[TBL] [Abstract][Full Text] [Related]
25. Fenretinide activates caspases and induces apoptosis in gliomas.
Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP
Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110
[TBL] [Abstract][Full Text] [Related]
26. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
27. Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin.
Kaufmann SH; Kalemkerian GP; Jasti R; Mabry M
Biochem Pharmacol; 1995 Dec; 50(12):1987-93. PubMed ID: 8849324
[TBL] [Abstract][Full Text] [Related]
28. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
29. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
30. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
[TBL] [Abstract][Full Text] [Related]
31. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.
Montaldo PG; Pagnan G; Pastorino F; Chiesa V; Raffaghello L; Kirchmeier M; Allen TM; Ponzoni M
Int J Cancer; 1999 Apr; 81(2):262-7. PubMed ID: 10188729
[TBL] [Abstract][Full Text] [Related]
32. Effects of retinoic acid (all-trans and 9-cis) on tumor progression in small-cell lung carcinoma.
Güzey M; Demirpençe E; Criss W; DeLuca HF
Biochem Biophys Res Commun; 1998 Jan; 242(2):369-75. PubMed ID: 9446801
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
Shan D; Gopal AK; Press OW
Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
[TBL] [Abstract][Full Text] [Related]
34. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
[TBL] [Abstract][Full Text] [Related]
35. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
Kabbout M; Hatoum A; Abou-Lteif G; Chakroun I; Homaidan FR; Darwiche N
Mol Carcinog; 2004 May; 40(1):12-23. PubMed ID: 15108326
[TBL] [Abstract][Full Text] [Related]
36. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
[TBL] [Abstract][Full Text] [Related]
37. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
38. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
39. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
Herbert BS; Sanders BG; Kline K
Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
